Please provide a link involving a past FDA sanctioned CT in 2nd line PC patients "tumor shrinkage".
And that explains why it hasn't been used for the last 20 yrs? Maybe because alkylating drugs especially used as monotherapy drugs, don't do too well in solid tumors. Science gets in the way again.